Analysis of the use of antidiabetics and antihypertensives in diabetes patients with comorbid hypertension at Puskesmas Mrebet
Article Sidebar
Main Article Content
Page: 331-338
Abstract
Diabetes Mellitus (DM) is a chronic disease characterised by high blood sugar levels. Diabetes mellitus is considered the "mother disease" because it is the mother of various diseases such as hypertension, heart disease, stroke, kidney failure and blindness. There were 13,117 DM cases in Purbalingga Regency, and 14,035 people were provided services according to procedures. Increased blood glucose levels (hyperglycemia) cause intravascular fluid resistance, which results in an increase in body fluid volume and an increase in peripheral arterial resistance. These two conditions are the basis for hypertension. There is a need for appropriate antidiabetic therapy to treat hypertension comorbid DM disorders. This research was conducted at the Mrebet Community Health Center, Purbalingga Regency, where the results obtained were 55 data on the use of prolanis medication for DM comorbid hypertension patients. In this study, the most common single therapy was metformin (12.7%), then the two most common combinations were glimepiride and acarbose (41.8%), while the three combinations used were metformin, glimepiride and acarbose (12.7%). The most common single antihypertensive was Lisinopril (28.2%), and the most common combination was Lisinopril + Amlodipine (28.2%).
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Abdulkadir Widi S, Djuwarno Endah, Rasdianah N, Akuba J, Tahir M.F. (2023). Potensi Interaksi Obat Antidiabetes Melitus Tipe-2 Dengan Obat Antihipertensi. Journal Syifa Sciences and Clinical Research.5(2): 245-252.
Adistia, E., Dini, I., & Annisaa', E. (2022). Hubungan antara rasionalitas penggunaan antihipertensi terhadap keberhasilan terapi pasien hipertensi di rsnd semarang. Generics Journal of Research in Pharmacy, 2(1), 24-36. https://doi.org/10.14710/genres.v2i1.13067
Altay Mustafat. (2022). Acarbose is Again On Stage—World Journal of Diabetes. 2022 Jan 15; 13(1): 1–4.
American Diabetes Association (ADA). (2015). Diagnosis and classification of diabetes Mellitus. American Diabetes Care, 38, 8–16
Ansa Dian , Goenawi Lily, Tjirosantoso Haeedy. (2011). Kajian penggunaan obat antihipertensi pada pasien diabetes melitus tipe 2 di instalasi rawat inap BLU RSUP Prof. DR. R. D. Kandou Manado. E-Journal ISTN
Ardhany, S., Pandaran, W., & Pratama, M. (2018). Profil penggunaan obat antihipertensi di rsud mas amsyar kasongan kabupaten katingan. Borneo Journal of Pharmacy, 1(1), 47-50. https://doi.org/10.33084/bjop.v1i1.248
Basit Abdul, Diaz Musaraffat, Fawwad Asyer. (2013). Glimepiride: evidence-based facts, trends, and observations. Vasc Health Risk Manag. ;9:1
Departemen Kesehatan. (2005). Pharmaceutical Care untuk Penyakit Diabetes Mellitus’, Departemen Kesehatan RI
Dinas Kesehatan Provinsi Jawa Tengah. (2021). Profil Kesehatan Provinsi Jawa Tengah 2018. Semarang.
Dinas Kesehatan Purbalingga. (2021). Profil Kesehatan Kabupaten Purbalingga 2021. Purbalingga.
DiPiro Joseph T., Gary C. Yee, Stuart T. Haines, Thomas D. Nolin, Vicki L. Ellingrod, L. Michael Posey.(2018). Pharmacotherapy A Pathophysiologic Approach, 10th Edition.
Diwati, A. and Sofyan, O. (2023). Profil dan rasionalitas penggunaan obat antihipertensi pada pasien hipertensi di fasilitas kesehatan tingkat pertama periode mei - juli 2021. Majalah Farmaseutik, 19(1), 1. https://doi.org/10.22146/farmaseutik.v19i1.80153
Fares H, DiNicolantonio J J, O’Keefe J H, Lavie C J. (2016) Amlodipine in hypertension: A first-line agent with efficacy for improving blood pressure and patient outcomes. Open Heart.; 3(2): 1–7.
Fathurrahman, M., Ardhiani, M., Faridah, I. N., Dania, H., Irham, L. M., & Perwitasari, D. A. (2023). Kepatuhan dan luaran terapi pada pasien diabetes melitus tipe 2 pengguna insulin di apotek x yogyakarta: compliance and treatment outcomes in type 2 diabetes mellitus patients using insulin at pharmacy x yogyakarta. Medical Sains: Jurnal Ilmiah Kefarmasian, 8(2), 519-528. https://doi.org/10.37874/ms.v8i2.745
Furdiyanti, H.N., et. al. (2017). Evaluasi Dosis dan Interaksi Obat Antidiabetika Oral pada Pasien Diabetes Melitus Tipe II. Semarang. Universitas Ngudi Waluyo
Inayah, Hamidi M.Y, Sari Mayang. (2017). Gambaran Terapi Diabetes Melitus Tipe 2 dengan Komorbid Hipertensi di Rumah Sakit X Pekanbaru. Jurnal Ilmu Kedokteran (Journal of Medical Science) 10(2):84
Kalra Sanjay et al. (2018). Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus - International Task Force. India J Metab Endocrinol. 2018. Jan -Februari ;22(1):132-157. doi: 10.4103/ijem.IJEM_556_17
Kementrian Kesehatan Republik Indonesia. (2020). Infodatin: Tetap Produktif, Cegah dan Atasi Diabetes Melitus
Lastra.G, Syed.S, Kurukulasuriya R, Manrique C, Sowers J R.. (2014). Type 2 diabetes mellitus and hypertension: An update. Metab Clin North Am. 43(1): 103–122
Lie, P., Irawati, S., & Presley, B. (2016). Prevention of cardiovascular disease in diabetes mellitus outpatient: focusing on antiplatelet, statins and irrational antihypertensive drug use. Indonesian Journal of Clinical Pharmacy, 5(3), 169-183. https://doi.org/10.15416/ijcp.2016.5.3.169
Lindsay A, Mclaver; Charles V. Preuss; Jayson Tripp. (2022). Acarbose. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK493214/ [diakses tanggal 10 Desember 2023]
Lopes Odgardo O., Pamar Mayur, Pendela V., Terrel J.M. (2023). Lisinopril. Statpearls. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK482230/
Mocanu MM, Madock H M., Baxter G F, Lawrence C L, Standen N B, Yellon DM. (2001). Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. Circulation;103(25):3111-6. doi: 10.1161/01.cir.103.25.3111
Nuraisyah, N., Ramadhan, A., & Sari, D. (2022). Evaluasi penggunaan obat pada pasien diabetes melitus dengan komplikasi stroke di rsud aji muhammad parikesit tenggarong tahun 2020. Proceeding of Mulawarman Pharmaceuticals Conferences, 15, 142-148. https://doi.org/10.25026/mpc.v15i1.633
Nurmainah, N., Fudholi, A., & Dwiprahasto, I. (2013). Persistensi penggunaan obat antihipertensi pada pasien hipertensi rawat jalan. Kesmas National Public Health Journal, 8(1), 13. https://doi.org/10.21109/kesmas.v8i1.336
Ohishi M. (2018). Hypertension with diabetes mellitus: physiology and pathology. Hypertens Res.; 41(6): 389-393
Pratama I Putu Y dan Ratnasari P M D. (2021). Pola Penggunaan Obat Pada Pasien Diabetes Melitus Tipe II dengan Komplikasi neuropati di Rumah Sakit Swasta di Bali. Acta Holistica Pharmaciana.Vol 3. No.2: 30-37
Puspitasari CE, Widiastuty R, Dewi Ni Made AR, Woro Oci Q, Syamsun Arfi. (2022). Profil Drug Related Problems (DRPs) pada Pasien Hipertensi di Instalasi Rawat Jalan Rumah Sakit Pemerintah di Kota Mataram Tahun 2018. Jurnal Sains dan Kesehatan. 2022. Vol 4. Special Issue 1
Regulski M, Regulska K, Stanisz BJ, Murias M, Gieremek P, Wzgarda A, Niznik B. (2015). Chemistry and Pharmacology of Angiotensin Converting Enzyme Inhibitor. Curr Farmasi. 21 (13):1764-75.
Rizal, R. (2022). Hubungan tingkat kepatuhan penggunaan obat antihipertensi pada fasilitas kesehatan tingkat pertama dan lanjutan. Jurnal Sains Dan Kesehatan, 6(1), 37-45. https://doi.org/10.57214/jusika.v6i1.94
Shuyan Gu et al, (2015). Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis. Plos One. 10(5): e0126704
Tahar, N., Parenta, E., Febriyanti, A., Rusdi, M., & Kautsar, A. (2021). Evaluasi tepat penggunaan obat lini pertama dan lini kedua antihipertensi pada pasien preeklampsia: a literatur review. Jurnal Midwifery, 3(2). https://doi.org/10.24252/jmw.v3i2.24341
Udayani Ni Nyoman W.,Wardani I Gusti AAK, Nida I Dewa Ayu AY. (2022). Evaluasi Efek Samping Penggunaan Obat Kombinasi Metformin dan Glimepiride pada Pasien Diabetes Melitus Tipe 2. Jurnal Ilmiah Medicanto. Vol.8 No.2
Warner NJ, Rush JE. (1988). Safety Profil of Angiotensin Converting Enzyme Inhibitor. 35 Tambahan 5:89-97.
Wikannanda Ida Ayu Amanda Dewi, Ni Luh Putu Eka Kartika Sari, Anak Agung Sri Agung Aryastuti. (2023). Gambaran Penggunaan Terapi Kombinasi Oral Metformin- Sulfonilurea pada Pasien DM Tipe 2 di Denpasar. e-Journal AMJ (Aesculapius Medical Journal) Vol. 3 No.2. 224 – 232
World Health Organization. (2019). Global report on diabetes.’ World Health Organization